Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.077 | 0.3 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |